drugset
drugset / Trial / NCT01467414

A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 2 Diabetes

NCT01467414 ↗

Phase 1 Terminated 1 enrolled Novo Nordisk A/S
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This trial is conducted in Europe. The aim of this clinical trial is to investigate the pharmacodynamic (the effect of the investigated drug on the body) properties of NN1250 (insulin degludec) in Japanese subjects with type 2 diabetes.

Timeline

Start
2011-10
Primary completion
2011-12
Completion
2011-12

Outcome

Outcome not reported

Stopped (Enrollment): “This trial was terminated due to low recruitment”

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin degludec Protein / enzyme biologic — Subcutaneous

Indications

type 2 diabetes mellitus